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ABSTRACT
A total of 97 V. parahaemolyticus isolate from Padang were examined for their resistance to 15
antibiotics. V. parahaemolyticus isolated behaved as resistant to sulfamethoxazole (100%),
rifampin (95%) and tetracycline (75%) and sensitive to norfloxacin (96%). Ampicillin still sensitive
for V. parahaemolyticus isolated from human stools. All of isolates were sensitive to namely
chloramphenicol and floroquinolones (ciprofloxacin and norfloxacin agents). RAPD-PCR profiling
with three primers (OPAR3, OPAR4 and OPAR8) produced four major clusters (R1, R2, R3 and
R4), 7 minor clusters (I, II, III, IV, V, VI and VII) and three single isolates.
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